Long-term opioid therapy trends in the VA: More intermittent than chronic

Cynthia Kay; Katherine Sherman; Rodney Sparapani

doi:10.5055/jom.0896

Authors

Cynthia Kay, MD, MS https://orcid.org/0000-0003-2649-6078
Katherine Sherman, MS
Rodney Sparapani, PhD

DOI:

https://doi.org/10.5055/jom.0896

Keywords:

veterans, long-term opioid therapy, opioid pattern

Abstract

Objective: To observe patterns of opioid therapy among veterans with a focus on long-term opioid therapy (LTOT).

Design: A retrospective study utilizing data from the Veterans Affairs Corporate Data Warehouse.

Subjects: Veterans 18 years or older, who received at least one outpatient opioid prescription between June 1, 2008, and June 1, 2018, and had no cancer, palliative care, or hospice encounters during the study period.

Main measures: For each patient, opioid prescriptions were combined into one contiguous prescription, as long as the gap (<7, <30, <90 days) between the end of supply and the receipt of the next fill met specified intervals. When gaps exceeded the threshold, a new prescription chain began. This was done to explore patterns of opioid fills.

Results: There were 746,658 patients with a prescription gap <7 days who received 5,084,346 contiguous opioid scripts. For all gap lengths, 16-35 percent of contiguous scripts lasted at least 90 days, 3-14 percent lasted more than a year, and 1-8 percent lasted 2 years. While a relatively small proportion of contiguous scripts were long-lasting, a substantial proportion of patients received long-lasting opioid therapy.

Conclusions: Long-term, intermittent opioid therapy was common. However, the long-term, monthly, uninterrupted opioid prescriptions expected with typical LTOT was not. It is likely that LTOT in past research was more reflective of periodic use instead of continuous, monthly prescriptions, especially for multiyear studies.

Author Biographies

Cynthia Kay, MD, MS

Associate Professor, Department of Medicine, Clement J. Zablocki VA Medical Center; Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin

Katherine Sherman, MS

Research Biostatistician, Research Division, Clement J. Zablocki VA Medical Center, Milwaukee, Wisconsin

Rodney Sparapani, PhD

Associate Professor, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin

References

Centers for Disease Control and Prevention: Understanding the opioid overdose epidemic. Available at https://www.cdc.gov/opioid/basics/epidemic.html. Accessed December 19, 2022.

Hedegaard H, Miniño AM, Spencer MR, et al.: Drug overdose deaths in the United States, 1999–2020. NCHS Data Brief No. 428. Hyattsville, MD: National Center for Health Statistics, 2021. DOI: 10.15620/cdc:112340.

Dowell D, Haegerich TM, Chou R: CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR Recomm Rep. 2016; 65(No. RR-1): 1-49. DOI: 10.15585/mmwr.rr6501e1.

Treede RD, Rief W, Barke A, et al.: A classification of chronic pain for ICD-11. Pain. 2015; 156(6): 1003-1007. DOI: 10.1097/j.pain.0000000000000160.

Braden JB, Russo J, Fan MY, et al.: Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med. 2010; 170(16): 1425-1432. DOI: 10.1001/archinternmed.2010.273.

Edlund MJ, Martin BC, Fan MY, et al.: Risks for opioid abuse and dependence among recipients of chronic opioid therapy: Results from the TROUP study. Drug Alcohol Depend. 2010; 112(1-2): 90-98. DOI: 10.1016/j.drugalcdep.2010.05.017.

Gaither JR, Goulet JL, Becker WC, et al.: The association between receipt of guideline-concordant long-term opioid therapy and all-cause mortality. J Gen Intern Med. 2016; 31(5): 492-501. DOI: 10.1007/s11606-015-3571-4.

Kay C, Wozniak E, Koller S, et al.: Adherence to chronic opioid therapy prescribing guidelines in a primary care clinic. J Opioid Manage. 2016; 12(5): 333-345. DOI: 10.5055/jom.2016.0350.

Kay C, Wozniak E, Ching A, et al.: Pain agreements and healthcare utilization in a veterans affairs primary care population: A retrospective chart review. Pain Ther. 2018; 7(1): 121-126. DOI: 10.1007/s40122-018-0098-5.

Kazis LE, Ameli O, Rothendler J, et al.: Observational retrospective study of the association of initial healthcare provider for new-onset low back pain with early and long-term opioid use. BMJ Open. 2019; 9(9): e028633. DOI: 10.1136/bmjopen-2018-028633.

Martin BC, Fan MY, Edlund MJ, et al.: Long-term chronic opioid therapy discontinuation rates from the TROUP study. J Gen Intern Med. 2011; 26(12): 1450-1457. DOI: 10.1007/s11606-011-1771-0.

Bedson J, Chen Y, Ashworth J, et al.: Risk of adverse events in patients prescribed long-term opioids: A cohort study in the UK clinical practice research datalink. Eur J Pain. 2019; 23(5): 908-922. DOI: 10.1002/ejp.1357.

Boudreau D, Von Korff M, Rutter CM, et al.: Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug. 2009; 18(12): 1166-1175. DOI: 10.1002/pds.1833.

Morden NE, Munson JC, Colla CH, et al.: Prescription opioid use among disabled Medicare beneficiaries: Intensity, trends and regional variation. Med Care. 2014; 52(9): 852-859. DOI: 10.1097/MLR.0000000000000183.

Smolina K, Gladstone EJ, Rutherford K, et al.: Patterns and trends in long-term opioid use for non-cancer pain in British Columbia, 2005-2012. Can J Public Health. 2016; 107(4-5): e404-e409. DOI: 10.17269/cjph.107.5413.

Von Korff M, Saunders K, Thomas Ray G, et al.: De facto long-term opioid therapy for noncancer pain. Clin J Pain. 2008; 24(6): 521-527. DOI: 10.1097/AJP.0b013e318169d03b.

Hadlandsmyth K, Mosher H, Vander Weg MW, et al.: Decline in prescription opioids attributable to decreases in long-term use: A retrospective study in the veterans health administration 2010–2016. J Gen Intern Med. 2018; 33: 818-824. DOI: 10.1007/s11606-017-4283-8.

US Department of Health and Human Services: Pain management best practices inter-agency task force report: Updates, gaps, inconsistencies, and recommendations. 2019. Available at https://www.hhs.gov/ash/advisory-committees/pain/reports/index.html pmtf-final-report-2019-05-23.pdf. Accessed January 19, 2023. Accessed December 26, 2022.

VA/DoD: Clinical practice guideline for opioid therapy for chronic pain version 3.0. Available at https://www.va.gov/HOMELESS/nchav/resources/docs/mental-health/substanceabuse/VA_DoD-CLINICAL-PRACTICE-GUIDELINE-FOR-OPIOIDTHERAPY-FOR-CHRONIC-PAIN-508.pdf. 2017. Accessed January 19, 2023.

QuickStats: Percentage of adults aged ≥20 years who had chronic pain, by veteran status and age group—National Health Interview Survey, United States, 2019. MMWR Morb Mortal Wkly Rep. 2020; 69: 1797. DOI: 10.15585/mmwr.mm6947a6externalicon.

US Department of Veterans Affairs: 172VA10P2: VHA corporate data warehouse—VA. 79 FR 4377. Updated (the last date of your record search). Available at https://www.sciencedirect.com/science/article/pii/S0304395907007506. Accessed December 12, 2012.

Centers for Disease Control and Prevention: US opioid dispensing rate maps. Available at https://www.cdc.gov/drugoverdose/rxrate-maps/index.html. Accessed June 1, 2022.

Sandbrink F, Oliva EM, McMullen TL, et al.: Opioid prescribing and opioid risk mitigation strategies in the veterans health administration. J Gen Intern Med. 2020; 35: 927-934. DOI: 10.1007/s11606-020-06258-3.

Hariharan J, Lamb GC, Neuner JM: Long-term opioid contract use for chronic pain management in primary care practice. A five year experience. J Gen Intern Med. 2007; 22(4): 485-490. DOI: 10.1007/s11606-006-0084-1.

VA/DoD: Clinical practice guideline for the management of opioid therapy for chronic pain version 1. 2003. Available at https://www.va.gov/painmanagement/docs/chronicpainguidelinesva2003.pdf. Accessed January 19, 2023.

Hadlandsmyth K, Mosher HJ, Bayman EO, et al.: A typology of new long-term opioid prescribing in the veterans health administration. J Gen Intern Med. 2020; 35: 2607-2613. DOI:

1007/s11606-020-05749-7.

Guy GP, Jr, Zhang K, Bohm MK, et al.: Vital signs: Changes in opioid prescribing in the United States, 2006–2015. MMWR Morb Mortal Wkly Rep. 2017; 66(26): 697-704. DOI: 10.15585/mmwr.mm6626a4.

Strickler GK, Kreiner PW, Halpin JF, et al.: Opioid prescribing behaviors—Prescription behavior surveillance system, 11 states, 2010–2016. MMWR Surveill Summ. 2020; 69(1): 1-14. DOI: 10.15585/mmwr.ss6901a1.

Zhu W, Chernew ME, Sherry TB, et al.: Initial opioid prescriptions among US commercially insured patients, 2012–2017. N Engl J Med. 2019; 380(11): 1043-1052. DOI: 10.1056/NEJMsa1807069.

Petzel RA: Opioid safety initiative requirements. Department of Veterans Affairs. 2014. Available at https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjCmf2A2cr9AhWjEVkFHd-_AZQQFnoECCcQAQ&url=https%3A%2F%2Fwww.vendorportal.ecms.va.gov%2FFBODocumentServer%2FDocumentServer.aspx%3FDocumentId%3D1626028%26FileName%3DVA257-14-R-1720-007.pdf&usg=AOvVaw3nujBVsW3j_U1D-mVrBlS. Accessed January 19, 2023.

United States Government Accountability Office: VA health care: Progress made towards improving opioid safety, but further efforts to assess progress and reduce risk are needed. 2018. Available at https://www.gao.gov/assets/gao-18-380.pdf. Accessed January 9, 2023.

Adams NJ, Plane MB, Fleming MF, et al.: Opioids and the treatment of chronic pain in a primary care sample. J Pain Symptom Manage. 2001; 22(3): 791-796. DOI: 10.1016/S0885-3924(01)00320-7.

Dahlhamer J, Lucas J, Zelaya C, et al.: Prevalence of chronic pain and high-impact chronic pain among adults—United States, 2016. MMWR Morb Mortal Wkly Rep. 2018; 67: 1001-1006. DOI: 10.15585/mmwr.mm6736a2.

Dahlhamer JM, Connor EM, Bose J, et al.: Prescription opioid use among adults with chronic pain: United States, 2019. Natl Health Stat Rep. 2021; 162: 1-9.

Tian TY, Zlateva I, Anderson DR: Using electronic health records data to identify patients with chronic pain in a primary care setting. J Am Med Inform Assoc. 2013; 20(e2): e275-e280. DOI: 10.1136/amiajnl-2013-001856.

Von Korff M, Dunn KM: Chronic pain reconsidered. Pain. 2008; 138(2): 267-276. DOI: 10.1016/j.pain.2007.12.010.

National Institutes of Health: Pathways to prevention workshop: The role of opioids in the treatment of chronic pain. 2014. Available at https://prevention.nih.gov/sites/default/files/documents/programs/p2p/ODPPainPanelStatementFinal_10-02-14.pdf Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain (nih.gov).

Betancourt JA, Granados PS, Pacheco GJ, et al.: Exploring health outcomes for US Veterans compared to non-veterans from 2003 to 2019. Healthcare. 2021; 9(5): 604. DOI: 10.3390/healthcare9050604.

Boersma P, Cohen RA, Zelaya CE, et al.: Multiple chronic conditions among veterans and nonveterans: United States. Natl Center Health Stat. 2021; 153: 2015-2018. DOI: 10.15620/cdc:101659.

Hoglund MW, Schwartz RM: Mental health in deployed and nondeployed veteran men and women in comparison with their civilian counterparts. Mil Med. 2014; 179(1): 19-25. DOI: 10.7205/MILMED-D-13-00235.

Mosher HJ, Richardson KK, Lund BC: The 1-year treatment course of new opioid recipients in veterans health administration. Pain Med. 2016; 17(7): 1282-1291. DOI: 10.1093/pm/pnw058.

Wickham H: Ggplot2: Elegant Graphics for Data Analysis. 2nd ed. Berlin: Springer International Publishing, 2016.

Zeileis A, Grothendieck G: Zoo: S3 infrastructure for regular and irregular time series. J Stat Softw. 2005; 14(6): 1-27. DOI: doi:10.18637/jss.v014.i06.

Zeileis A, Fisher JC, Hornik K, et al.: Colorspace: A toolbox for manipulating and assessing colors and palettes. J Stat Softw. 2020; 96(1): 1-49. DOI: 10.18637/jss.v096.i01.